Loading…

Emergent BioSolutions signed a three-year agreement valued at approximately $65 million to supply NARCAN Nasal Spray to the Ontario Ministry of Health for the Ontario Naloxone Program, supporting opioid overdose prevention.
“Emergent BioSolutions signed a $65 million contract to supply NARCAN® Nasal Spray to Ontario's Naloxone Program for opioid overdose prevention.”quiverquant.com
Summarized from public sources; check the original articles before acting on it.